Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10822995rdf:typepubmed:Citationlld:pubmed
pubmed-article:10822995lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C0801658lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C0019638lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C0005957lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C0024314lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:10822995lifeskim:mentionsumls-concept:C0814812lld:lifeskim
pubmed-article:10822995pubmed:dateCreated2000-8-17lld:pubmed
pubmed-article:10822995pubmed:abstractTextThe aim of his overview is to provide some insight into the manifold applications of bone marrow examination in lymphoproliferative disease. Having a large selection of methods any clinician working in this field should be familiar with the diagnostic relevance of each method for a given diagnostic problem. The choice of the appropriate investigations will warrant a correct diagnosis and helps to lower health expenses. Because of the multiplicity of the methods, often performed at different institutions, a lot of confusion can be caused by conflicting interpretation of isolated results. A diagnosis should never be based on isolated findings such as immunophenotyping or demonstration of a clonal population. Results of various investigations are to be integrated into a final diagnostic concept, which will be the basis for therapeutic decisions.lld:pubmed
pubmed-article:10822995pubmed:languageenglld:pubmed
pubmed-article:10822995pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10822995pubmed:citationSubsetIMlld:pubmed
pubmed-article:10822995pubmed:statusMEDLINElld:pubmed
pubmed-article:10822995pubmed:issn0033-2240lld:pubmed
pubmed-article:10822995pubmed:authorpubmed-author:HurwitzNNlld:pubmed
pubmed-article:10822995pubmed:issnTypePrintlld:pubmed
pubmed-article:10822995pubmed:volume57 Suppl 1lld:pubmed
pubmed-article:10822995pubmed:ownerNLMlld:pubmed
pubmed-article:10822995pubmed:authorsCompleteYlld:pubmed
pubmed-article:10822995pubmed:pagination37-41lld:pubmed
pubmed-article:10822995pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10822995pubmed:meshHeadingpubmed-meshheading:10822995...lld:pubmed
pubmed-article:10822995pubmed:meshHeadingpubmed-meshheading:10822995...lld:pubmed
pubmed-article:10822995pubmed:meshHeadingpubmed-meshheading:10822995...lld:pubmed
pubmed-article:10822995pubmed:meshHeadingpubmed-meshheading:10822995...lld:pubmed
pubmed-article:10822995pubmed:meshHeadingpubmed-meshheading:10822995...lld:pubmed
pubmed-article:10822995pubmed:year2000lld:pubmed
pubmed-article:10822995pubmed:articleTitleBone marrow examination for primary diagnosis and follow-up in patients with lymphoproliferative disorders. An overview with emphasize on bone marrow histology.lld:pubmed
pubmed-article:10822995pubmed:affiliationInstitut für Pathologie Kantonsspital Basel-Universitäa-Kliniken, Basel, Switzerland.lld:pubmed
pubmed-article:10822995pubmed:publicationTypeJournal Articlelld:pubmed